Our Team
Prof. Larry Ming Cheung Chow
Prof. Chow is a biochemist with over 30 years of experience in cancer research, parasitic disease research, translational research and drug development. His industrial partners include Kinex Ltd, Athenex Ltd and Aptus Therapeutics Ltd. He has collaborated with Athenex Ltd. in an UICP project which resulted in the successful approval of IND status by the USFDA in 2017.
Dr. Iris Lai King Wong
Dr. Wong is a biologist with over 15 years of experience in pre-clinical study including in vitro, in vivo efficacy study, set-up platform for high throughput drug screening, set-up cancer and parasitic disease animal models and drug resistance mechanism study.
Prof. Bill Tak Hang Chan
Prof. Chan is a medicinal chemist with over 50 years of experience in cancer research, translational research, drug discovery, drug development and medicinal chemistry. He has considerable experience in collaboration beyond academia. He had served as consultant to Dow Corning Chemicals, USA (1989‑1991), Bristol‑Myers Laboratory, Canada (1983‑1994), Darwin Pharma, Canada (2004-2006) and Viteava Pharmaceuticals Inc., Canada (2013-2016). He had received research support from pharmaceutical companies including Bristol-Myers Laboratory (Canada), Merck Frosst Co. (Canada) and Scinopharm Co. (Taiwan).
Dr. Gege Sun
Dr. Sun is a biologist with over 4 years of experience in pre-clinical study including in vitro, in vivo efficacy study, drug resistance mechanism study and cancer tumor tissue microarray.